Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,074.00
-22.00 (-2.01%)
At close: Dec 5, 2025
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 83.38 billion as of December 5, 2025. Its market cap has decreased by -25.51% in one year.
Market Cap
83.38B
Enterprise Value
-21.57B
Revenue
72.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,074.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 83.38B, a decrease of -61.66%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 83.38B | -26.71% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | 869.25B | 57.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.54T |